Holocene Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Holocene Advisors's LLY Position: Q2 2026 in Review
Holocene Advisors reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2026, selling an estimated $11.1M and leaving 176,517 shares worth $212M. The position accounts for 0.48% of the portfolio, ranked #55.
Holocene Advisors first reported a position in LLY in Q4 2017 and has held it in 16 quarters since. The position peaked at $530M in Q2 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Holocene Advisors held 176,517 shares of Eli Lilly worth $212M as of Q2 2026.
- Holocene Advisors sold 10,842 Eli Lilly shares in Q2 2026, an estimated $11.1M.
- Eli Lilly made up 0.48% of Holocene Advisors's portfolio in Q2 2026, its #55 holding.
- Holocene Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 16 quarters since.
- Holocene Advisors's Eli Lilly position peaked at $530M in Q2 2025.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.